Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer - PubMed (original) (raw)
Comparative Study
Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer
S Ganesh et al. Br J Cancer. 1997.
Free PMC article
Abstract
Despite the advances in pre-, peri- and post-operative medical care of colorectal carcinoma patients, the prognosis has improved only marginally over recent decades. Thus, additional prognostic indicators would be of great clinical value to select patients for adjuvant therapy. In previous studies we found that colorectal carcinomas have a marked increase of the urokinase-type of plasminogen activator (u-PA), and the inhibitors PAI-1 and PAI-2, whereas the tissue-type plasminogen activator (t-PA) is found to be decreased in comparison with adjacent normal mucosa. In the present study we evaluated the prognostic value of several plasminogen activation parameters, determined in both normal and carcinomatous tissue from colorectal resection specimens, for overall survival of 136 Dukes' stage B and C colorectal cancer patients, in relation to major clinicopathological parameters. Uni- and multivariate analyses indicated that a high PAI-2 antigen level in carcinoma, a low t-PA activity and antigen level and a high u-PA/t-PA antigen ratio in adjacent normal mucosa are significantly associated with a poor overall survival. A high ratio of u-PA antigen in the carcinomas and t-PA antigen in normal mucosa, i.e. u-PA(C)/t-PA(N), was found to be predictive of a poor overall survival as well. All these parameters were found to be prognostically independent of the clinicopathological parameters. Multivariate analysis of combinations of these prognostically significant plasminogen activation parameters revealed that they are important independent prognostic indicators and have in fact a better prognostic value than their separate components. Based on these combined parameters, subgroups of patients with Dukes' stage B and C colorectal cancer could be identified as having either a high or a low risk regarding overall survival. In conclusion, these findings emphasize the relevance of the intestinal plasminogen activation system for survival prognosis of patients with colorectal cancer and, in the future, might constitute a patient selection criterion for adjuvant therapy.
Similar articles
- Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.
Ganesh S, Sier CF, Griffioen G, Vloedgraven HJ, de Boer A, Welvaart K, van de Velde CJ, van Krieken JH, Verheijen JH, Lamers CB, et al. Ganesh S, et al. Cancer Res. 1994 Aug 1;54(15):4065-71. Cancer Res. 1994. PMID: 8033138 - Prognostic value of the plasminogen activation system in patients with gastric carcinoma.
Ganesh S, Sier CF, Heerding MM, van Krieken JH, Griffioen G, Welvaart K, van de Velde CJ, Verheijen JH, Lamers CB, Verspaget HW. Ganesh S, et al. Cancer. 1996 Mar 15;77(6):1035-43. doi: 10.1002/(sici)1097-0142(19960315)77:6<1035::aid-cncr5>3.0.co;2-g. Cancer. 1996. PMID: 8635120 - Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis.
Sier CF, Verspaget HW, Griffioen G, Verheijen JH, Quax PH, Dooijewaard G, De Bruin PA, Lamers CB. Sier CF, et al. Gastroenterology. 1991 Dec;101(6):1522-8. doi: 10.1016/0016-5085(91)90387-z. Gastroenterology. 1991. PMID: 1955118 - Prognostic value of plasminogen activators and their inhibitors in colorectal cancer.
Verspaget HW, Sier CF, Ganesh S, Griffioen G, Lamers CB. Verspaget HW, et al. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1105-9. doi: 10.1016/0959-8049(95)00170-n. Eur J Cancer. 1995. PMID: 7577001 Review. - Fibrinolysis components as prognostic markers in breast cancer and colorectal carcinoma.
Gandolfo GM, Conti L, Vercillo M. Gandolfo GM, et al. Anticancer Res. 1996 Jul-Aug;16(4B):2155-9. Anticancer Res. 1996. PMID: 8694536 Review.
Cited by
- Impact of proteolytic enzymes in colorectal cancer development and progression.
Herszényi L, Barabás L, Hritz I, István G, Tulassay Z. Herszényi L, et al. World J Gastroenterol. 2014 Oct 7;20(37):13246-57. doi: 10.3748/wjg.v20.i37.13246. World J Gastroenterol. 2014. PMID: 25309062 Free PMC article. Review. - MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients.
Langers AM, Verspaget HW, Hawinkels LJ, Kubben FJ, van Duijn W, van der Reijden JJ, Hardwick JC, Hommes DW, Sier CF. Langers AM, et al. Br J Cancer. 2012 Apr 24;106(9):1495-8. doi: 10.1038/bjc.2012.80. Br J Cancer. 2012. PMID: 22472880 Free PMC article. - Regulation of the human plasminogen activator inhibitor type 2 gene: cooperation of an upstream silencer and transactivator.
Stringer B, Udofa EA, Antalis TM. Stringer B, et al. J Biol Chem. 2012 Mar 23;287(13):10579-10589. doi: 10.1074/jbc.M111.318758. Epub 2012 Feb 9. J Biol Chem. 2012. PMID: 22334683 Free PMC article. - ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer.
Mazzoccoli G, Pazienza V, Panza A, Valvano MR, Benegiamo G, Vinciguerra M, Andriulli A, Piepoli A. Mazzoccoli G, et al. J Cancer Res Clin Oncol. 2012 Mar;138(3):501-11. doi: 10.1007/s00432-011-1126-6. Epub 2011 Dec 24. J Cancer Res Clin Oncol. 2012. PMID: 22198637 - Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.
Van Buren G 2nd, Gray MJ, Dallas NA, Xia L, Lim SJ, Fan F, Mazar AP, Ellis LM. Van Buren G 2nd, et al. Cancer. 2009 Jul 15;115(14):3360-8. doi: 10.1002/cncr.24371. Cancer. 2009. PMID: 19484792 Free PMC article.
References
- Surg Gynecol Obstet. 1978 Feb;146(2):257-9 - PubMed
- Cancer Res. 1992 Nov 1;52(21):6101-5 - PubMed
- Rehabil Nurs. 1981 Jan-Feb;6(1):11-5 - PubMed
- Cancer. 1981 Mar 1;47(5):930-6 - PubMed
- Thromb Haemost. 1982 Dec 27;48(3):266-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous